Physician profile
David Chi
NPI 1164494688
$3,695.74
in general payments reported to CMS, 2019-2025
10 companies · $2,610 in 2025
The $2,610 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $14.64 · 2021: $74.37 · 2022: $213 · 2023: $121 · 2024: $295 · 2025: $2,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,275 · Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,275.00 |
| Food and Beverage | $750.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iotamotion, INC. | $2,346.02 | 2024-2025 | Iotasoft |
| Intuitive Surgical, INC. | $467.09 | 2019-2024 | |
| Advanced Bionics, LLC | $251.34 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Davol INC. | $150.03 | 2022 | |
| Smith+Nephew, INC. | $121.19 | 2023-2024 | Tula, Coblation |
| Stryker Corporation | $112.72 | 2022-2025 | Scopis Ent, Xpress Ent Dilation System |
| Preceptis Medical, INC. | $76.92 | 2024 | Hummingbird Tympanostomy Tube System |
| Takeda Pharmaceuticals U.S.A., INC. | $74.37 | 2021 | |
| Cochlear Americas | $53.50 | 2020-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Medtronic, INC. | $42.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.